Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: Relationship between skin rash and survival (Pantar study)
- Aranda, E.
- Manzano, J.L.
- Rivera, F.
- Galán, M.
- Valladares-Ayerbes, M.
- Pericay, C.
- Safont, M.J.
- Mendez, M.J.
- Irigoyen, A.
- Arrivi, A.
- Sastre, J.
- Díaz-Rubio, E.
ISSN: 0923-7534, 1569-8041
Year of publication: 2012
Volume: 23
Issue: 7
Pages: 1919-1925
Type: Article